Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
Stock Chart Patterns
Earnings Trading
AI Screener

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. AKTX

Stock Price & Analysis

-
stocks logo
AKTX
-
$
0.000
0.000(0%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

AKTX Stock Price Chart

5D
1M
3M
6M
YTD
1Y
5Y

AKTX Key Stats

High
Vol
Low
Amount
Open
VWAP
Mkt Cap

AKTX Company Profile

banner

AKTX Technical Analysis

Instant technical analysis with one click on any asset

banner

AKTX Why It Moves

Find out the reasons behind the current stock movement

banner

Should I Buy AKTX

AI-powered analysis to guide your buy, sell, or hold decision for this stock

banner

AKTX News Sentiment

AI uncovers potential trading opportunities based on news sentiment

banner

AKTX Technical Analysis

Instant technical analysis with one click on any asset

banner

AKTX Why It Moves

Find out the reasons behind the current stock movement

banner

Should I Buy AKTX

AI-powered analysis to guide your buy, sell, or hold decision for this stock

banner

AKTX News Sentiment

AI uncovers potential trading opportunities based on news sentiment

AKTX Fundamental Analysis

Moderate Buy
Buy
Hold
Sell
bubble
High
bubble
Averages
bubble
Low
Analyst
Rating
Action
Price Target
Date
Rating Reason

AKTX News

AKTX FAQs

What is surpport and resistant level for AKTX Stock?

The S1 support level for AKTX Stock is $1.11 ,The R1 resistant level for AKTX Stock is $1.36.

What is the current price of AKTX Stock?

As of the end of day on 2025-02-05, the price of AKTX Stock was $1.14.

What is the market cap of Akari Therapeutics PLC?

The market cap of AKTX is $29.0M.

What is Akari Therapeutics PLC (AKTX)'s business?

Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. Its pipeline includes a Phase 3 clinical trial program investigating nomacopan for severe pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA). The Company has been granted Orphan Drug, Fast Track and Rare Pediatric Disease designations from the United States Food and Drug Administration (FDA) for nomacopan for the treatment of pediatric HSCT-TMA. Additionally, the Company has a pre-clinical program developing long-acting PASylated-nomacopan (PAS-nomacopan) for treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (dry AMD).

How many employees does AKTX have?

AKTX has a total of 9 employees.

AKTX Key Stats

High
Vol
Low
Amount
Open
VWAP
Mkt Cap

AKTX Company Profile

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free